LimFlow

The deal includes$250 million in cash upfront and additional payments based on reaching commercial and reimbursement milestones.

Vascular device maker Inari Medical announced plans to buy surgical system company LimFlow for up to $415 million.

Announces Q3 2023 Financial Results Inari to Host Conference Call Today at 1:30 P.M PT / 4:30 P.M. ET IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (

New Therapeutic Option Has Potential to Reduce Rate of Major Limb Amputation in U.S. PARIS AND SAN JOSE, CALIF. - 09/12/2023 - LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia

PROMISE II Trial Met Primary Endpoint Therapy Demonstrates 76% Limb Salvage in Patients with Chronic Limb-Threatening Ischemia Who Otherwise Faced Amputation PARIS - March 30, 2023 - LimFlow SA, a pioneer in the development of minimally-invasive technolog

Positive results from Limflow SA's PROMISE II U.S. pivotal trial show its Limflow system for transcatheter arterialization of deep veins (TADV) led to sustained amputation-free survival and wound healing in patients with chronic limb-threatening ischemia

PARIS-December 6, 2022-LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced the appointment of Mike Mathi